Results 51 to 60 of about 32,366 (248)

Juvenile idiopathic arthritis-associated uveitis [PDF]

, 2016
Juvenile idiopathic arthritis (JIA) is the most common rheumatic disease of childhood, with JIA-associated uveitis its most common extra-articular manifestation.
Clarke, Sarah, Ramanan, Athimalaipet, Sen, Ethan   +2 more
core   +3 more sources

Effectiveness and Safety of Baricitinib for Juvenile Idiopathic Arthritis–Associated Uveitis or Chronic Anterior Antinuclear Antibody–Positive Uveitis

Arthritis Care &Research, EarlyView.
Objective To evaluate the efficacy and safety of baricitinib in pediatric patients with active juvenile idiopathic arthritis–associated uveitis (JIA‐U) or chronic anterior antinuclear antibody–positive uveitis, who had an inadequate response to methotrexate (MTX) or biologic disease‐modifying antirheumatic drugs (bDMARDs).
Athimalaipet V. Ramanan, Catherine M. Guly, Gabriele Simonini, Stuart Y. Keller, Priyanka Sen, Thorsten Holzkaemper, Joana Araújo, Pierre Quartier   +7 more
wiley   +1 more source

A comparison of three treatment strategies in recent onset non-systemic Juvenile Idiopathic Arthritis: Initial 3-months results of the BeSt for Kids-study [PDF]

, 2017
Background: Combination therapy with prednisone or etanercept may induce earlier and/or more improvement in disease activity in Disease Modifying Anti Rheumatic Drug (DMARD) naïve non-systemic Juvenile Idiopathic Arthritis (JIA) patients. Here we present
Allaart, C.F. (Cornelia), Bekkering, W.P. (Peter), Berg, J.M. (Merlijn) van den, Brederije, I.C.J., Brinkman, D.M.C., Cate, R. (Rebecca) ten, Hissink Muller, P.C.E. (Petra), Koopman-Keemink, Y. (Yvonne), Kuijpers, T.W. (Taco W.), Rossum, M.A.J. (Marion) van, Schonenberg, D., Suijlekom-Smit, L.W.A. (Lisette) van   +11 more
core   +1 more source

Accuracy of Diagnostic Codes and Algorithms Used to Identify Rheumatoid Arthritis and Juvenile Idiopathic Arthritis in Administrative Claims and Electronic Health Records: Systematic Review and Meta‐Analysis

Arthritis Care &Research, EarlyView.
Objective This systematic review aimed to assess the diagnostic accuracy of algorithms used to identify rheumatoid arthritis and juvenile idiopathic arthritis in electronic health records. Methods We searched Medline, Embase, and Cochrane Central Register for Controlled Trials databases and included studies that validated case definitions against a ...
Constanza Saka‐Herrán, Jessica Bennett, Yara Alkabti, Muhammad Fatir, Barbara Clyne, Caroline McCarthy, Gráinne Tynan, Nikki Dunne, Michelle Flood, Eoghan McCarthy, Frank Moriarty   +10 more
wiley   +1 more source

Thalidomide for systemic onset juvenile idiopathic arthritis

Indian Pediatrics, 2013
Systemic onset juvenile idiopathic arthritis (SOJIA) is the most common autoimmune auto inflammatory disease in childhood. A sizeable number of these patients run a recalcitrant disease course, resistant to the conventional line of management, ultimately resulting in permanent disability from joint destruction, local growth deformities or iatrogenic ...
K, Sathe, R P, Khubchandani
openaire   +2 more sources

Juvenile Idiopathic Arthritis

Balkan Medical Journal, 2017
Juvenile idiopathic arthritis is the most common chronic rheumatic disease of unknown aetiology in childhood and predominantly presents with peripheral arthritis.
Kenan Barut, Amra Adrovic, Sezgin Şahin, Özgür Kasapçopur   +3 more
doaj   +1 more source

Sarilumab in Polyarticular‐Course Juvenile Idiopathic Arthritis: Dose‐Finding and One‐Year Analysis of a Phase 2b, Open‐Label, Multicenter Study

Arthritis Care &Research, Accepted Article.
Objective This study assessed sarilumab in treating patients with polyarticular‐course juvenile idiopathic arthritis (pcJIA). Methods This phase 2b, open‐label study (NCT02776735) consisted of three sequential parts (each with a core‐treatment and extension‐phase). During part 1, three doses were assessed in two weight groups (Group A/B: ≥30–60 kg/≥10–<
Fabrizio De Benedetti, Inmaculada C. Penadés, Irina Nikishina, Ivan Foeldvari, Alberto J. Spindler, Anna Kozlova, Nadina Rubio‐Pérez, Pierre Quartier, Zbigniew Żuber, Raul Barria, Daniel Clemente, Gabriel V. Cornejo, Katherine Marzan, Nancy Liu, Christine Xu, Stephen DiMartino, Angeliki Giannelou, Fei Cao‐Ghoul, Bolanle Akinlade, Lydie Baret‐Cormel   +19 more
wiley   +1 more source

Comparison of biomarkers for systemic juvenile idiopathic arthritis [PDF]

Pediatric Research, 2015
Differentiation of systemic juvenile idiopathic arthritis (SJIA) fever from other childhood fevers is often delayed due to the lack of reliable, specific biomarkers. We hypothesized that PD-L1 expression is dysregulated in SJIA monocytes and compared it to other candidate SJIA biomarkers.This pilot study enrolled children with fever without source and ...
Susan, Shenoi, Jing-Ni, Ou, Chester, Ni, Claudia, Macaubas, Vivian H, Gersuk, Carol A, Wallace, Elizabeth D, Mellins, Anne M, Stevens   +7 more
openaire   +2 more sources

Macrophage activation syndrome in systemic juvenile idiopathic arthritis [PDF]

Immunological Medicine, 2021
Macrophage activation syndrome (MAS) is a severe, potentially life-threatening complication of systemic juvenile idiopathic arthritis (s-JIA). An immunological feature is the excessive activation and proliferation of T lymphocytes and macrophages. Massive hypercytokinemia is strongly associated with its pathogenesis, particularly the overproduction of ...
openaire   +3 more sources

Systemic Treatment for Temporomandibular Joint Arthritis in Juvenile Idiopathic Arthritis [PDF]

The Journal of Rheumatology, 2020
Within the last decade, intensified research has highlighted the orofacial consequences of juvenile idiopathic arthritis (JIA) involving the temporomandibular joint (TMJ). It has been documented that about 40% of subjects with JIA develop involvement of the TMJ1,2. Smaller studies have reported even higher frequencies of TMJ involvement3. TMJ arthritis
PETER STOUSTRUP, MARINKA TWILT, TROELS HERLIN   +2 more
openaire   +3 more sources